Synchronous thyroid tumor biopsy and therapeutic biodegradable magnesium alloy implantation device

By implanting biodegradable magnesium-copper alloy microneedle during thyroid tumor biopsy, the problem of major trauma and many complications in traditional surgical and thermal ablation techniques is solved, and a low-risk, low-cost thyroid cancer treatment plan is provided. in patients who cannot tolerate surgery.

CN118975823APending Publication Date: 2024-11-19SHENYANG SHENGKE MEIJIA BIOMEDICAL TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411071341.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-06
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

Among the existing treatment methods for thyroid cancer, surgical and thermal ablation techniques have problems such as major trauma, many complications, and it is difficult to avoid local tissue damage and recurrence, especially for patients with intolerable surgery or small papillary thyroid cancer. plan.

Method used

A concurrent thyroid tumor biopsy and therapeutic biodegradable magnesium alloy implantation device is designed. The magnesium-copper alloy microneedle is implanted into the lesion site during the biopsy process through ultrasound guidance, and combined with antibacterial properties, non-open surgical treatment is achieved.

Benefits of technology

While reducing the patient's recovery time and cost, the device avoids the risk of secondary surgery, significantly reduces the incidence of inflammatory response and complications, and provides a low-risk thyroid cancer treatment plan, especially suitable for PTMC patients.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118975823A_ABST
    Figure CN118975823A_ABST
Patent Text Reader

Abstract

The invention belongs to the field of thyroid tumor biopsy and treatment, and particularly relates to a synchronous thyroid tumor biopsy and therapeutic biodegradable magnesium alloy implantation device which is suitable for non-open surgical treatment of biodegradable MgCu alloy implants. One end of a hollow biopsy needle of the device is inserted into one end of a transparent needle handle, and one end of a push rod is inserted into the other end of the transparent needle handle; the outer side of the other end of the transparent needle handle is provided with a Luer interface, and the other end of the transparent needle handle is matched and connected with a corresponding female Luer taper through the Luer interface; a magnesium alloy microneedle is arranged on the upper portion of a hollow inner cavity of the biopsy needle, the front end of the magnesium alloy microneedle is a tip end, a position blocking piece is arranged on the biopsy needle on the outer side of the magnesium alloy microneedle, the position blocking piece is elastic and corresponds to the magnesium alloy microneedle in shape, the front end of the position blocking piece extends into the biopsy needle, and the rear end of the magnesium alloy microneedle is a plane. And one end of the push rod extends into the hollow inner cavity of the biopsy needle and corresponds to the rear end of the magnesium alloy microneedle.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of thyroid tumor biopsy and treatment, and specifically relates to a simultaneous thyroid tumor biopsy and therapeutic biodegradable magnesium alloy implant device, which is suitable for non-open surgical treatment of biodegradable MgCu alloy implants, mainly for PTMC, thyroid tumor patients who cannot tolerate surgery or cannot be removed by surgery. Background Art

[0002] Thyroid cancer is the most common malignant tumor in the endocrine system, and the increasing number of new cases has attracted great attention from all walks of life. The pathological types of thyroid cancer include differentiated thyroid cancer (DTC), anaplastic or undifferentiated thyroid cancer (ATC) and medullary thyroid cancer (MTC). Among them, differentiated thyroid cancer includes papillary thyroid carcinoma (PTC), follicular thyroid carcinoma (FTC) and poorly differentiated thyroid cancer (PDTC). Among these five pathological types, PTC is the most common, accounting for about 85% to 90% of thyroid malignant tumors. Papillary thyroid microcarcinoma (PTMC) refers to a papillary thyroid carcinoma with a diameter of 1.0 cm. It has a very good prognosis and an overall mortality rate lower than .

[0003] ≤1% [doi:10.3390 / cancers12051345]. In recent years, due to the development of imaging technology, the number of PTMCs discovered accidentally in the past has increased rapidly. For this relatively indolent and stable cancer, some experts believe that there is overdiagnosis and even overtreatment [doi:10.1007 / s00268-022-06770-z]. The American Thyroid Association (ATA) guidelines recommend that active monitoring can be considered for PTMC patients without obvious metastasis or local spread, as well as patients with a short remaining life span and high surgical risk. However, in clinical practice, some patients who have been actively monitored for a long time still have local infiltration or lymph node metastasis. In addition, once some patients are diagnosed with PTMC, they will have varying degrees of anxiety and uneasiness about the tumor-carrying status, and are willing to accept relatively active interventions instead of active monitoring, which leads to excessive intensive treatment for patients. Surgery is more traumatic to patients, and complications such as parathyroid injury and hypothyroidism are likely to occur after surgery.

[0004] As an emerging minimally invasive treatment method, thermal ablation technology has shown broad application prospects in the treatment of thyroid cancer. This technology has the advantages of easy operation, few complications, and preservation of thyroid function. It has been widely used in the treatment of recurrent thyroid cancer and thyroid micropapillary carcinoma, and is recommended by many domestic and international guidelines. The treatment cost is about 10,000 to 15,000 yuan. Thermal ablation technology includes laser ablation, radiofrequency ablation, microwave ablation and other forms, all of which heat the local tissue to 60°C or above to achieve the purpose of damaging the target tissue. Although the value of thermal ablation in the treatment of benign thyroid nodules has been recognized by multiple domestic and international guidelines, its application in the treatment of thyroid cancer is still a highly controversial topic, focusing mainly on the following three aspects: (1) The safety margin of thermal ablation: Unlike other organs such as the liver and kidneys, the thyroid gland is smaller in size and adjacent to important structures such as the trachea, blood vessels, and nerves. How to completely inactivate the tumor while protecting the surrounding important structures from thermal damage is a challenge faced by thermal ablation in the treatment of thyroid cancer; (2) Treatment of regional lymph nodes: Lymph node metastasis is prone to occur in the early stages of thyroid cancer, especially in the central zone. However, the sensitivity of preoperative ultrasound and CT in identifying metastatic lymph nodes in the central zone is limited, which can easily lead to the omission of positive lymph nodes; (3) Thermal ablation increases the difficulty of reoperation. Thermal ablation can cause local tissue degeneration and necrosis, which can manifest as edema, adhesion, and fibrosis over time, increasing the difficulty of surgical operations and affecting the safety and thoroughness of the operation.

[0005] In recent years, magnesium metal (Mg) has shown great application potential in the field of medical devices due to its special biodegradability, good mechanical properties and excellent biocompatibility (PMID: 30965229). Studies have shown that increased levels of Mg ions in serum can reduce the risk of colon cancer and primary liver cancer (PMID: 31167754, PMID: 32105342). Nude mouse tumor formation experiments have shown that Mg ion injection can inhibit the growth of colon cancer cells (PMID: 36006540). Magnesium degradation can also lead to OH - Increase, resulting in an alkaline environment, which is also a key factor in inhibiting the growth of tumor cells (PMID: 35386318). In addition, studies have shown that magnesium-copper alloys (such as Mg0.2Cu, Cu content 0.2wt%, the rest is Mg) continuously release magnesium ions and copper ions in a physiological environment at the same time, and their dissolution rate is within the range that the body can withstand, so it will not affect biological safety. The release of Cu ions in the alkaline environment brought about by this will have a dual antibacterial effect on bacteria such as Staphylococcus aureus, combining alkaline antibacterial and copper ion antibacterial (PMID: 27271057), see a biodegradable magnesium alloy with strong antibacterial function (publication number CN104645422A).

[0006] At present, the relevant patents for magnesium-based alloy anti-tumor are:

[0007] (1) Publication No.: CN115612902A, Jia Qingan et al. prepared a magnesium-based alloy micron particle that synergizes with TACE in anti-liver cancer effect. The magnesium-based alloy micron particle is prepared with magnesium metal as a carrier and other metal particles with anti-cancer effect. The magnesium-based alloy micron particle is locally implanted into tumor tissue before TACE treatment. In the early stage, it reverses the negative effects of TACE through degradation-induced alkaline microenvironment, anti-oxidation and other methods. In the final stage, it is degraded to nano-scale particle size and then internalized by cells to directly exert anti-cancer effect in the cells. This provides a new anti-tumor implant material that can reverse the negative effects of TACE and enhance the anti-liver cancer efficacy of TACE, thus benefiting the survival of clinical malignant tumor patients.

[0008] (2) Publication No.: CN116254445A, Wang Leyun et al. developed a method for preparing a Mg-Al-Ca ternary magnesium alloy and its use as an anti-tumor implant material or magnetic hyperthermia medium. The magnetic thermal heating of the Mg-Al-Ca alloy wire, combined with its faster degradation rate, can inhibit the growth of large-diameter tumors, and its tumor inhibition effect is significantly better than that of pure magnesium. Currently, there is no research and clinical program on the use of biodegradable magnesium alloy implants to treat thyroid cancer. Summary of the invention

[0009] The purpose of the present invention is to provide a simultaneous thyroid tumor biopsy and therapeutic biodegradable magnesium alloy implantation device, which can simultaneously obtain thyroid tissue samples by fine needle puncture under ultrasound guidance and implant biodegradable MgCu alloy into the lesion site, and also has antibacterial properties.

[0010] The technical solution of the present invention:

[0011] A biodegradable magnesium alloy implant device for simultaneous thyroid tumor biopsy and treatment, the device comprises a biopsy needle, a blocking piece, a magnesium alloy microneedle, a scale mark, a transparent needle handle, a Luer interface, and a push rod, and the specific structure is as follows:

[0012] One end of the hollow biopsy needle is inserted into one end of the transparent needle handle, and one end of the push rod is inserted into the other end of the transparent needle handle; a Luer interface is arranged on the outer side of the other end of the transparent needle handle, and is matched and connected with a corresponding female Luer connector through the Luer interface; a magnesium alloy microneedle is arranged on the upper part of the hollow inner cavity of the biopsy needle, and the front end of the magnesium alloy microneedle is a pointed end, and a stopper is arranged on the outer side of the magnesium alloy microneedle on the biopsy needle, the stopper is elastic and corresponds to the shape of the magnesium alloy microneedle, the front end of the stopper extends into the biopsy needle, and the rear end of the magnesium alloy microneedle is a plane, one end of the push rod extends into the hollow inner cavity of the biopsy needle and corresponds to the rear end of the magnesium alloy microneedle, and a scale mark is opened on the side of the biopsy needle.

[0013] The size of the magnesium alloy microneedle of the simultaneous thyroid tumor biopsy and therapeutic biodegradable magnesium alloy implantation device is: diameter Φ=0.2mm-0.8mm, length 3mm-6mm.

[0014] The simultaneous thyroid tumor biopsy and therapeutic biodegradable magnesium alloy implant device, the magnesium alloy microneedle is made of magnesium-copper alloy Mg0.2Cu.

[0015] The simultaneous thyroid tumor biopsy and therapeutic biodegradable magnesium alloy implantation device directly sets the magnesium alloy microneedle in the biopsy needle, and implants the magnesium alloy microneedle into the lesion while completing the biopsy sampling.

[0016] The simultaneous thyroid tumor biopsy and therapeutic biodegradable magnesium alloy implantation device implants the tumor therapeutic magnesium alloy microneedle in the biopsy needle into the lesion through a push rod under ultrasound-assisted guidance, and the simultaneous biopsy needle takes thyroid tissue samples around the implanted material.

[0017] The simultaneous thyroid tumor biopsy and therapeutic biodegradable magnesium alloy implantation device provides a scale mark on the biopsy needle to calculate the insertion depth during puncture.

[0018] When the simultaneous thyroid tumor biopsy and therapeutic biodegradable magnesium alloy implant device is used, the needle is inserted layer by layer along a predetermined puncture path in the patient's thyroid tissue under ultrasound guidance to reach the lesion; the magnesium alloy microneedle customized according to the size of the lesion before the operation is implanted into the lesion, and samples are collected around the implanted magnesium alloy microneedle. After sampling, the biopsy needle is withdrawn; the biopsy needle is retracted, the wound is disinfected and bandaged, and the operation is completed.

[0019] The design concept of the present invention is:

[0020] At present, there is only a single method of puncture biopsy for thyroid cancer. The simultaneous thyroid tumor biopsy and therapeutic device of the present invention are the first of their kind. Ultrasound-guided fine needle aspiration has become the main method for preoperative diagnosis of thyroid cancer. It has the characteristics of low cost and convenient operation, and can also guide the biopsy area in real time. The traditional surgical method for thyroid cancer is unilateral / bilateral thyroidectomy + central lymph node dissection + therapeutic lateral neck lymph node dissection, which can reduce the patient's postoperative recurrence and metastasis rate, but it is also easy to cause parathyroid damage, and the patient faces lifelong thyroid hormone administration after surgery, and the surgical incision neck leaves a scar, which is not conducive to the improvement of the patient's prognosis and quality of life. Therefore, the present invention develops a simultaneous thyroid tumor biopsy and therapeutic biodegradable magnesium alloy implant microneedle, and while taking a thyroid tissue sample by thyroid body biopsy, the magnesium-copper alloy is implanted into the lesion site. This implant has good biocompatibility and degradability, and can gradually degrade in the body to exert its anti-cancer effect, avoiding the risk and discomfort of secondary surgery and reducing the patient's recovery time and cost [doi:10.1016 / J.JMA.2023.02.007]. At the same time, the antibacterial properties of magnesium-copper alloy can reduce the inflammatory response caused by invasive operations. This non-open surgical treatment strategy is mainly aimed at PTMC, or patients with thyroid tumors who cannot tolerate surgery and cannot be removed by surgery, but surgical treatment is still recommended for high-risk PTMC, which can be used as an alternative for patients with low-risk PTMC.

[0021] The advantages and beneficial effects of the present invention are:

[0022] 1. Advantages in materials:

[0023] (1) The antibacterial ability of magnesium-based alloys with anti-tumor effects in the past is insufficient;

[0024] (2) Based on the invention patent "A biodegradable magnesium alloy with strong antibacterial function (publication number CN104645422A)", further research found that magnesium-copper alloy (Mg0.2Cu) has low toxicity to normal thyroid cells while taking into account antibacterial and anti-tumor capabilities;

[0025] (3) The mechanical properties of Mg0.2Cu alloy are significantly higher than those of pure Mg, making it more suitable for the clinical application of the biodegradable magnesium alloy implantable microneedles invented in this patent.

[0026] 2. Advantages in treatment:

[0027] Surgery + Radiotherapy 131 I treatment + thyroid hormone suppression therapy is a common treatment for thyroid cancer. These treatments can effectively control the disease and improve the patient's prognosis. However, hypothyroidism after surgery is a common problem. Patients need to take thyroid hormone replacement therapy for life, which will cause great damage to the patient's body. In addition, iodine ( 131 I) Treatment will affect the patient's salivary gland function, leading to dry mouth; some patients may also experience complications such as cervical lymphedema, hoarseness (if the recurrent laryngeal nerve is damaged during surgery) or hypoparathyroidism; at the same time, surgery cannot solve problems such as patients' intolerance to surgery (PMID: 34871424). Thermal ablation technology is commonly used in the clinic to treat benign thyroid nodules, but its use in the treatment of thyroid cancer is still a highly controversial topic and can cause a series of adverse reactions, including local pain, bleeding, recurrent laryngeal nerve damage, tumor recurrence, etc.

[0028] 3. Operational advantages:

[0029] During the same period, thyroid lesion puncture biopsy combined with magnesium-copper alloy implantation can select the best puncture surface according to the patient's ultrasound image, pay attention to avoiding arterial blood vessels, and determine the direction and angle of needle insertion. Use local anesthesia and segmented needle insertion. After needle insertion, choose the appropriate depth, and use ultrasound to assist in confirming whether the direction, angle and depth of needle insertion are appropriate. When the biopsy needle tip penetrates the tumor lesion, the guide needle (push rod) implants the therapeutic magnesium-copper alloy into the lesion. Further biopsies are taken around the implanted material, and the lesion tissue obtained by the biopsy is immersed in formaldehyde solution for specimen fixation. After fixation, a pathological examination is performed. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] Figure 1-Figure 2 This is a schematic diagram of the structure of the biodegradable magnesium alloy implant device for thyroid tumor biopsy and treatment at the same time. Figure 1 For the main view, Figure 2 for Figure 1 Enlarged view of point A in .

[0031] In the figure: 1-biopsy needle, 2-blocking plate, 3-magnesium alloy microneedle, 4-scale mark, 5-transparent needle handle, 6-Luer interface, 7-push rod.

[0032] Figure 3-Figure 18 The results of the study on the anti-thyroid cancer activity of biodegradable magnesium-based metals are as follows: Figure 3MTT method was used to detect the effects of Ti, Mg, and Mg0.2Cu alloy extracts on the proliferation inhibition rate of thyroid cancer cells. (a) Human papilloma thyroid cancer cell TPC1, (b) Human thyroid cancer cell BHT-101, (c) Human normal thyroid cell line NTHY-ORI 3-1, the horizontal axis Time is time (h), and the vertical axis OD Value is optical density. Figure 4 Live and dead cell staining was used to observe the toxicity of Ti, Mg, and Mg0.2Cu alloy extracts on thyroid cancer cells (human papillomatous thyroid cancer cells TPC1 and human thyroid cancer cells BHT-101, at 12h and 24h, respectively. Live is a typical picture of live cell staining, Dead is a typical picture of dead cell staining, and Merge is an overlapping picture of a typical picture of live cell staining and a typical picture of dead cell staining). Figure 5 The cell clone formation experiment was used to detect the effects of Ti, Mg, and Mg0.2Cu alloy extracts on the clone formation ability of thyroid cancer cells. (a) Typical cell clone staining image of human papilloma thyroid cancer cell TPC1, (b) Statistical graph of human papilloma thyroid cancer cell TPC1 clone formation (the vertical axis represents the number of clones), (c) Typical cell clone staining image of human thyroid cancer cell BHT-101, (d) Statistical graph of human thyroid cancer cell BHT-101 clone formation (the vertical axis represents the number of clones). Figure 6 The cell scratch experiment was used to detect the effects of Ti, Mg, and Mg0.2Cu alloy extracts on the migration ability of thyroid cancer cells. (a) Cell migration diagram of human papilloma thyroid cancer cell TPC1 at 0h, 12h, and 24h, respectively; (b) Cell migration rate statistics of human papilloma thyroid cancer cell TPC1 (the horizontal axis represents time (h), and the vertical axis wound closure rate represents cell migration rate); (c) Cell migration diagram of human thyroid cancer cell BHT-101 at 0h, 12h, and 24h, respectively; (d) Cell migration rate statistics of human thyroid cancer cell BHT-101 (the horizontal axis represents time (h), and the vertical axis wound closure rate represents cell migration rate). Figure 7Transwell experiment was used to detect the effects of Ti, Mg, and Mg0.2Cu alloy extracts on the invasion and migration of thyroid cancer cells. (a) The effects of human papilloma thyroid cancer cell TPC1 on migration and human thyroid cancer cell BHT-101 on migration. The four figures in each group from left to right are the cell migration status and cell migration statistics of Ti, Mg, and Mg0.2Cu alloy groups (the vertical axis Migrated cells per field represents the number of migrated cells in each field of view); (b) The effects of human papilloma thyroid cancer cell TPC1 on invasion and human thyroid cancer cell BHT-101 on invasion. The four figures in each group from left to right are the cell invasion status and cell invasion statistics of Ti, Mg, and Mg0.2Cu alloy groups (the vertical axis Invaded cells per field represents the number of invaded cells in each field of view); Figure 8 Scanning electron microscopy was used to observe the effects of Ti, Mg, and Mg0.2Cu alloy extracts on the formation of filopodia in thyroid cancer cells. (a) Human papillomatous thyroid cancer cell TPC1, (b) Human thyroid cancer cell BHT-101. Fig. 9 In order to perform immunofluorescence labeling on the cytoskeletal proteins F-actin and ɑ-tublin, the effects of Ti, Mg, and Mg0.2Cu alloy extracts on the extension state of the thyroid cancer cell skeleton were observed under a confocal microscope. (a) Human papilloma thyroid cancer cell TPC1, (b) Human thyroid cancer cell BHT-101, (a) and (b) in the upper figures, F-action, Ki67, DAPI, and Merge represent the cytoskeletal staining fluorescence image, Ki67 staining fluorescence image, cell nucleus staining fluorescence image, and the overlapping image of the three fluorescence images, respectively; (a) and (b) in the lower figures, Tubulin, DAPI, and Merge represent the ɑ-tublin protein staining fluorescence image, cell nucleus staining fluorescence image, and the overlapping image of the two fluorescence images, respectively. Fig.10 Flow cytometry was used to detect the effects of Ti, Mg, and Mg0.2Cu alloy extracts on apoptosis of thyroid cancer cells. (a) Human papillomatous thyroid cancer cell TPC1, (b) Human thyroid cancer cell BHT-101. The abscissa Annexin-V-FITC represents the relative number of Annexin V-bound cells, and the ordinate PI represents the relative number of PI-stained cells. Fig.11 This is a flow chart of the thyroid cancer tumor-bearing nude mouse model. Tumor stands for tumor, Alloy stands for alloy, Alloy implantation tumor stands for alloy implantation tumor, and Hemostasis stands for hemostasis. Fig.12Photos of nude mice in each group were implanted with Ti, Mg, and Mg0.2Cu alloys and then killed on the 14th day of treatment. Fig.13 Tumor specimens peeled off on the 14th day after the nude mice were implanted with Ti, Mg, and Mg0.2Cu alloys (a) and statistical graphs of tumor weights of subcutaneous transplanted tumors in nude mice of each group (b). Tumor volume is the tumor volume (mm 3 ). Fig.14 Micro-CT images of 6 nude mice in each group implanted with Ti, Mg, and Mg0.2Cu alloys on the 14th day of treatment. The left side of each group shows the local tumor site of the nude mice, and the right side of each group shows the overall image of the corresponding nude mice. Fig.15 The pH value (a) and corrosion rate (b) of Mg and Mg0.2Cu metal materials immersed in simulated liquid for different time periods are shown in Figure 2. pH value is the pH value, and Corrosion Rate is the corrosion rate (mm / y). Fig.16 To investigate the morphological effects of Ti, Mg, and Mg0.2Cu alloys on the liver, spleen, and kidney of nude mice 14 days after implantation. Fig.17 Figure 3. Fixation process of rabbit thyroid tissue after Ti, Mg, and Mg0.2Cu alloy implantation and serum FT3 and FT4 levels 14 days after surgery. (a) Rabbit implantation position, (b) serum FT3 detection sampling, (c) serum FT3 detection results, (d) serum FT4 detection sampling, and (e) serum FT4 detection results. Fig.18 The morphological effects of Ti, Mg, and Mg0.2Cu alloys on the surgical and contralateral sides of rabbit thyroid tissue 14 days after implantation. DETAILED DESCRIPTION

[0033] like Figure 1-Figure 2 As shown, the present invention proposes a biodegradable magnesium alloy implant device for simultaneous thyroid tumor biopsy and treatment, which mainly includes a biopsy needle 1, a blocking piece 2, a magnesium alloy microneedle 3, a scale mark 4, a transparent needle handle 5, a Luer interface 6, and a push rod 7. The specific structure is as follows:

[0034] One end of the hollow biopsy needle 1 is inserted into one end of the transparent needle handle 5, and one end of the push rod 7 is inserted into the other end of the transparent needle handle 5; a Luer interface 6 is arranged on the outside of the other end of the transparent needle handle 5, and is matched and connected with the corresponding female Luer connector through the Luer interface 6; a magnesium alloy microneedle 3 is arranged on the upper part of the hollow inner cavity of the biopsy needle 1, and the front end of the magnesium alloy microneedle 3 is a sharp tip, and a stopper 2 is arranged on the outer side of the magnesium alloy microneedle 3 on the biopsy needle 1, and the stopper 2 is elastic and corresponds to the shape of the magnesium alloy microneedle 3, and the front end of the stopper 2 extends into the biopsy needle 1, and the rear end of the magnesium alloy microneedle 3 is a plane, and one end of the push rod 7 extends into the hollow inner cavity of the biopsy needle 1 and corresponds to the rear end of the magnesium alloy microneedle 3, and a scale mark 4 is opened on the side of the biopsy needle 1. The size of the magnesium alloy microneedle 3 is: diameter Φ = 0.2mm ~ 0.8mm, length 3mm ~ 6mm.

[0035] The present invention directly sets the magnesium alloy microneedle 3 in the biopsy needle 1, and implants the magnesium alloy microneedle 3 into the lesion while completing the biopsy sampling. That is, under ultrasound-assisted guidance, the tumor therapeutic magnesium alloy microneedle 3 in the biopsy needle 1 is implanted into the lesion through the push rod 7, and the biopsy needle 1 simultaneously takes thyroid tissue samples around the implanted material. The present invention performs interventional treatment and tissue biopsy at the same time to avoid the damage caused to the patient by repeated punctures. Fundamentally, for patients who need simultaneous target lesion puncture biopsy combined with interventional treatment, it solves the problems of intolerance to traditional surgery and thermal ablation, and at the same time solves the puncture-related complications such as tissue damage and bleeding that occur in patients after surgery due to the need for multiple extractions and punctures, thereby greatly reducing the incidence of complications.

[0036] The present invention provides a scale mark 4 on the biopsy needle 1, which facilitates the calculation of the insertion depth during puncture, making the measurement more convenient and quick, and improving the operation efficiency. The transparent needle handle 5 can facilitate the observation of the puncture and pushing process, and the Luer interface 6 can facilitate the connection of the matching female Luer connector part. When in use, ① insert the needle layer by layer along the predetermined puncture path in the patient's thyroid tissue under ultrasound guidance to reach the lesion; ② implant the lesion according to the magnesium alloy microneedle 3 customized according to the size of the lesion before the operation, sample the area around the implanted magnesium alloy microneedle 3, and withdraw the biopsy needle 1 after sampling; ③ retract the biopsy needle 1, disinfect and bandage the wound, and the operation is completed.

[0037] Magnesium is one of the most abundant light elements on earth, and its material cost is extremely low. Magnesium is an essential nutrient for the human body and is involved in almost all life activities of the human body. Degraded magnesium ions will not cause toxicity, and magnesium implants will gradually degrade in the human body after surgery, and no large amount of foreign matter will remain in the body. OH is continuously generated during the degradation process. -, hydrogen and magnesium ions, will have an inhibitory effect on tumors. The experimental research carried out for the present invention also confirmed its significant tumor killing effect, and used a variety of experimental animals (nude mice, rabbits) to confirm its biological safety. At the same time, the absorption spectrum presented by magnesium-based metals under X-rays is obvious, and even under magnetic resonance imaging, it will not interfere with surrounding tissues, which is conducive to postoperative diagnosis and imaging observation.

[0038] Magnesium can have a good inhibitory effect on bacterial survival due to the local alkaline environment produced by its degradation, which can inhibit the formation of biofilm and reduce the risk of infection. The magnesium alloy microneedle 3 can be made of magnesium copper alloy (Mg0.2Cu), and after adding Cu with antibacterial effect, the antibacterial performance is more excellent.

[0039] The method of using magnesium alloy microneedles to treat thyroid cancer during thyroid tumor biopsy proposed in the present invention is a brand-new thyroid treatment technology. Biodegradable microneedles are implanted for interventional treatment while the patient is undergoing biopsy, which has a therapeutic effect on thyroid cancer. The biopsy and interventional treatment are performed at the same time, avoiding the complications caused by repeated punctures, and can make up for or replace traditional surgery and thermal ablation technology, as shown in the following specific performances:

[0040] 1. Materials:

[0041] Low cost, anti-tumor effect, good mechanical properties, antibacterial effect

[0042] 1. Low cost:

[0043] China is the country with the richest magnesium resources in the world. The main production areas include Shanxi, Liaoning, Ningxia, Shaanxi, Henan and other provincial administrative regions. Fugu County in Yulin City, Shaanxi Province is one of the main production areas of magnesium in China, with rich magnesium ore resources. The abundant storage and low price of magnesium raw materials have laid a material foundation for its widespread application.

[0044] 2. Anti-tumor effect:

[0045] The present invention is a pioneering new technology for tumor treatment. At the cellular level, the CCK-8 method was used to detect and confirm that pure magnesium and magnesium-copper alloy extracts have an inhibitory effect on the growth of thyroid cancer cells TPC-1 and BHT-101, but have no significant cytotoxic effect on the normal human thyroid cell line NTHY-ORI 3-1. Pure magnesium and magnesium-copper alloy extracts showed significant tumor cell growth inhibition on two thyroid cancer cells at 6 hours, and the tumor cell inhibition effect became more obvious as time went on. In the cell live / dead staining experiment, it was found that after co-culture with tumor cells for 12 hours and 24 hours, different degrees of cell death could be observed in the pure magnesium and magnesium-copper alloy extract groups, and the number of dead cells increased with the extension of culture time. The results of the clone formation experiment showed that pure magnesium and magnesium-copper alloy extracts could inhibit the clone formation ability of thyroid cancer cells. The results of the scratch experiment and the Transwell experiment showed that pure magnesium and magnesium-copper alloy extracts could significantly reduce the number of transmembrane invasion and migration cells and the relative migration rate of cells. Scanning electron microscopy results showed that pure magnesium and magnesium-copper alloy extracts could inhibit pseudopodia formation in thyroid cancer cells. Fluorescence confocal microscopy observations on cell morphology and cytoskeletal proteins F-actin and α-tublin showed that pure magnesium and magnesium alloy extracts could affect the rearrangement of F-actin in cells, but no significant changes were observed in the effect on α-tublin. Flow cytometry Annexin V-FITC / PI double staining results showed that after 24 hours of co-culture with tumor cells, the apoptosis rate (early and late) of pure magnesium and magnesium-copper combined groups was significantly increased compared with the control group, which increased the apoptosis rate of thyroid cancer cells and induced cell apoptosis.

[0046] At the animal level, a nude mouse subcutaneous xenograft model of thyroid cancer cells was constructed. The experiment was divided into three groups, namely the pure titanium group, the pure magnesium group, and the magnesium-copper alloy group, with 6 mice in each group. Thyroid cancer cells in the logarithmic growth phase of each group were injected subcutaneously into nude mice, and tumors could form in the armpit of one side of the nude mice. When the tumor volume reached 50mm 3Pure titanium, pure magnesium, and magnesium-copper alloy filaments of the same specifications were implanted into the tumor for 2 weeks. Micro-CT was performed on nude mice in each group, and the tumor was peeled off and weighed. The results showed that the tumors in the pure magnesium group and the magnesium-copper alloy group showed significant ablation, and the tumor volume was significantly reduced, while the pure titanium group had no effect. The biosafety of the material was tested at the animal level (nude mice and rabbits), that is, liver, spleen and kidney tissues were taken from nude mice in the pure titanium group, pure magnesium group and magnesium-copper alloy group, and HE-stained sections were made. The results showed that there was no significant difference in HE staining among the three groups, indicating that magnesium-based metals have no obvious toxicity to animal tissues. After these materials were implanted into the unilateral thyroid of female New Zealand white rabbits for 14 days, the thyroid function and morphological changes of the rabbits were detected. The results showed that there was no significant difference in the morphology, size and color Doppler imaging of the thyroid glands on the surgical and control sides of the three groups of rabbits. However, the thyroid free T3 (FT3) and free T4 (FT4) in the rabbits of the pure magnesium group and the magnesium-copper alloy group were significantly reduced, indicating that the implantation of magnesium-based metals for 14 days would significantly affect the changes in the body's thyroid function. However, the morphology and size of the thyroid follicles and epithelial cells on the surgical and contralateral sides of the three groups of rabbits were normal, and no obvious lymphocyte infiltration and interstitial fibrosis were observed. The above results suggest that the direct effect of magnesium-based metals on the thyroid gland may mainly manifest as functional changes without causing obvious histological changes. This functional change may be due to changes in the local microenvironment caused by the implantation of magnesium-based metals, such as pH changes, ion release, etc., which affect the synthesis and release of thyroid hormones.

[0047] 3. Good mechanical properties:

[0048] The mechanical properties of magnesium-based metals were tested by a universal testing machine. The results showed that the magnesium-keto alloy would undergo obvious degradation in simulated body fluids, and the degradation rate was not significantly different from that of pure magnesium. As shown in Table 1, with the addition of copper content in the alloy, the tensile strength (Rm) of the cast magnesium-keto alloy increased from (87±5) MPa without copper addition to (220±10) MPa, and the elongation at break (%) increased from 11.05% to 15.15%, indicating that Mg0.2Cu alloy has better strength and plasticity as a puncture implant material, which is beneficial to clinical application and lays a material foundation for interventional treatment of thyroid tumors.

[0049] Table 1 is a comparison of the maximum force, tensile strength and yield strength of Mg and Mg0.2Cu metal materials

[0050]

[0051] The experimental method adopted in the present invention is as follows:

[0052] 1. MTT method:

[0053] Thyroid cancer cells TPC-1 and BHT-101 in the logarithmic growth phase and normal human thyroid cell line NTHY-ORI3-1 were evenly inoculated into a 96-well plate, 200 μL per well. After 24 hours of cell attachment, the cells were grouped and given metal Ti, Mg, and Mg0.2Cu extracts. Each group had 4 replicate wells and was cultured in an incubator for 6 hours, 12 hours, 18 hours, and 24 hours, respectively. 20 μL of MTT solution was added to each well and the cells were cultured in the incubator for 4 hours. The supernatant was discarded and 150 μL of DMSO was added. The plate was read at 492 nm and shaken for 300 seconds for measurement and recording.

[0054] 2. Live and dead cell staining:

[0055] After the TPC-1 and BHT-101 cells were treated with metal Ti, Mg, and Mg0.2Cu extracts for 12 h and 24 h, the well plates were washed twice with sterile PBS buffer, and 500 μL 1×Assay Buffer and 0.5 μL LiveDye and 0.5 μL NucleiDye mixed staining solution were added to each well and incubated at 37°C in the dark for 20 min. The well plates were washed twice with PBS buffer, and the living and dead cells were observed under a fluorescence microscope, and the number of cells was counted using Image J software.

[0056] 3. Plate colony formation experiment

[0057] The cells to be tested in the logarithmic growth phase were plated at 1×10 3 Inoculate in 6-well plates and mark, add 2mL of fresh culture medium to each well. After the cells adhere to the wall, discard the original culture medium, add metal Ti, Mg, Mg0.2Cu leaching solution to treat the fresh culture medium according to the experimental grouping, and place it in the incubator for about 2 weeks. The culture medium can be replaced every 4 days during this period. In the late stage of culture, observe the bottom of the 6-well plate. If there is a clone group visible to the naked eye or the cells form a monoclonal colony of at least 50 cells under a low-power microscope, stop the culture and discard the culture medium. Wash with PBS buffer 3 times, add 1mL of 4wt% paraformaldehyde to each well, fix at room temperature for 30min, remove the fixative, wash 3 times with PBS buffer, and then add 1mL of 0.1wt% crystal violet staining solution to each well, and stain at room temperature for 20min. Recover the staining solution, gently wash the cells 3 times with double distilled water until the staining solution is completely washed away, invert the 6-well plate at room temperature to dry, take pictures and count the number of colonies formed.

[0058] 4. Cell scratch test

[0059] Draw straight lines through the holes on the back of the 6-well plate with a black marker, and draw 3 lines in each hole, making sure that the 3 lines are even and parallel. 6) were inoculated in the above-mentioned 6-well plate with 2mL complete medium and cultured overnight. When the cell confluence reached 100%, the cell monolayer was scratched with a 200μL sterile yellow gun tip. When scratching, pay attention to uniform strength and parallel movement of the gun tip so that the scratch intersects vertically with the pre-drawn marking line. Sterile PBS buffer was added to each well to wash the cells 3 times, and the detached and suspended cells were removed. The scratch photos of the cells were observed under an inverted microscope and taken at 0h. According to the experimental grouping, the fresh culture medium was treated with metal Ti, Mg, and Mg0.2Cu extracts, and the intervention was 0h, 12h, and 24h. The supernatant culture medium was discarded, the cells were washed 3 times with sterile PBS buffer, the suspended cells were removed, and the cell scratch healing photos were observed under a microscope and taken. Image J software was used to process and calculate the cell migration rate.

[0060] 5. Transwell experiment

[0061] The cell concentration of each group treated accordingly was adjusted to 2.5×10 4 / mL, 200μL serum-free medium was used to dilute the cells to prepare a cell suspension, which was added to the upper chamber of Transwell, and 500μL complete medium was added to the lower chamber of Transwell. The bubbles between the chamber and the liquid surface were removed. After the chamber adhered to the wall, the old medium was discarded. According to the experimental grouping, the metal Ti, Mg, and Mg0.2Cu extracts were added to treat the fresh medium and intervened for 24h. The 24-well plate was taken out to remove the culture medium from the upper and lower chambers of Transwell, and the unmigrated cells on the inner side of the upper membrane of the chamber were gently wiped with a cotton swab and washed 3 times with PBS buffer. The cells under the membrane of the chamber were fixed with 4wt% paraformaldehyde for 20min and washed 3 times with PBS buffer. Subsequently, the cells under the membrane of the chamber were stained with 0.1wt% crystal violet staining solution for 5min, the staining solution was recovered, and the staining solution was gently rinsed off with running water. After natural air drying, the chamber was placed on a slide, observed under an upright microscope, and photographed and recorded.

[0062] 6. Scanning electron microscopy observation of cell pseudopodia formation experiment

[0063] The cells of each group to be tested were divided into 4 Each well was evenly inoculated into a 24-well plate with a built-in cell climbing slide. After the cells adhered to the wall, metal Ti, Mg, and Mg0.2Cu extracts were added to treat the fresh culture medium according to the experimental grouping. The cells were intervened for 24 hours and the supernatant was removed.

[0064] a. Pre-fixation: Add 500 μL of 2.5 wt% glutaraldehyde phosphate buffer at pH 7.4 to each well and fix in a 4°C refrigerator for more than 2 hours.

[0065] b. Washing: After removing the supernatant, add 500 μL of phosphoric acid soaking solution to each well and place in a 4°C refrigerator overnight.

[0066] c. Post-fixation: After removing the supernatant, add 500 μL of 1 wt% osmium acid to each well and fix in a 4°C refrigerator for more than 2 h.

[0067] d. Washing: After discarding the supernatant, wash with phosphoric acid solution three times at room temperature, each time for 5 minutes.

[0068] e. Gradient dehydration: prepare 1 portion of 50% ethanol, 70% ethanol, 80% ethanol, 90% ethanol, 95% ethanol and anhydrous ethanol respectively, add the above reagents into a 24-well plate for 5 min each and perform dehydration treatment in sequence: 50% ethanol (in a 4°C refrigerator), 70% ethanol (in a 4°C refrigerator), 80% ethanol (room temperature), 90% ethanol (room temperature), 95% ethanol (room temperature, 2 times), anhydrous ethanol (room temperature, 3 times).

[0069] f. Drying: Aspirate the anhydrous ethanol in each well and place in a 37°C drying oven to dry for 2 days.

[0070] g. Sputtering and observation: Take out the cell slide from the 24-well plate and put it into an ion sputtering instrument to spray gold onto the cell surface. Take out the slide and observe and photograph it under a scanning electron microscope.

[0071] 7. Confocal scanning microscopy observation

[0072] The cells of each group to be tested were divided into 4Each well was evenly inoculated into a 24-well plate with a built-in cell climbing slide. After the cells adhered to the wall, metal Ti, Mg, and Mg0.2Cu extracts were added to treat the fresh culture medium according to the experimental grouping. The cells were intervened for 24 hours and the supernatant was removed. In the culture plate, the slides with cells crawled were rinsed 3 times with PBS buffer, fixed with 4wt% paraformaldehyde for 15min, rinsed with PBS buffer 3 times, permeabilized with 0.5wt% Triton X-100 (prepared with PBS buffer) at room temperature for 20min, rinsed with PBS buffer 3 times, dried with PBS buffer, added with 5wt% BSA solution (weighed 0.5g bovine serum albumin, added with 10ml PBS buffer) on the slides, blocked at room temperature for 30min, and the blocking solution was absorbed with absorbent paper. Without washing, sufficient diluted Ki67 and Tublin primary antibodies (diluted 1:100 with PBS buffer) were added to each slide, placed in a wet box, and incubated overnight at 4°C, rinsed with PBS buffer 3 times, and dried with PBS buffer. Phalloidin was used to detect F-actin. The slides with cells crawled on the culture plate were washed with PBS buffer for 3 times, 5 μL / mL FITC-phalloidin was added for staining at room temperature in the dark for 45 minutes, and the slides were washed with PBS buffer for 3 times. The Cy3-labeled fluorescent secondary antibody diluted at a mass ratio of 1:150 was added dropwise, and the slides were incubated in a wet box at room temperature in the dark for 1 hour, and the slides were washed with PBS buffer for 3 times. DAPI was added dropwise and incubated in the dark for 10 minutes, the specimens were stained with nuclei, and the slides were washed with PBS buffer for 3 times. The liquid on the crawled slides was blotted with absorbent paper and observed under a laser confocal scanning microscope.

[0073] 8. Cell apoptosis detection

[0074] Collect the original culture medium of each group of cells and place it in a labeled sterile centrifuge tube. After washing the cells twice with sterile PBS, use an appropriate amount of EDTA-free trypsin to digest the cells and observe the cells until they are completely digested. Add complete culture medium to terminate digestion, gently blow off the cells and transfer the cell suspension to the centrifuge tubes containing the original culture medium in the above groups, centrifuge at 1500rpm, 4℃ for 5min, and discard the supernatant in the clean bench. Wash the cells twice with pre-cooled sterile PBS, centrifuge at 1500rpm, 4℃ for 5min. Remix the cell pellet with 100μL 1×Binding Buffer, add 5μL Annexin V-FITC and 5μL PI Staining Solution, blow gently, incubate at room temperature in the dark for 10min, add 400μL 1×Binding Buffer and mix, then detect on flow cytometer, and use FlowJo software to analyze the apoptosis rate of each group.

[0075] 9. Animal experiment (nude mouse tumor formation experiment)

[0076] a. Purchase 18 BALB / c-nu female nude mice, check their health status, and randomly divide them into 3 groups, 6 mice in each group, and breed them in an SPF environment for 3 days.

[0077] b. Digest the logarithmically growing TPC-1 cells with trypsin and place them in a centrifuge tube. Note that the digestion time should not be too long to avoid affecting the cell growth state. Adjust the cell concentration to 5×10 6 Each centrifuge tube, wash the cells once with sterile PBS buffer, and obtain the cell pellet after centrifugation. Dilute Matrigel with serum-free cell culture medium at a mass ratio of 8:1, and take 200 μL to resuspend the cell pellet.

[0078] c. Place each group of cell suspension EP tubes in a sterile aluminum lunch box, and then place the lunch box in an ice box to prevent the EP tube from directly contacting the ice, which may cause the cell suspension to freeze and tiny ice crystals to pierce the cells. At the same time, the low temperature ensures that the cells are in a low metabolic state. Prepare needles, iodine cotton balls, etc. and bring them into the animal room.

[0079] d. Take out the nude mouse, hold the skin on the back of the nude mouse with your left hand to fix it, turn the nude mouse over, and disinfect the inoculation site under the armpit of the nude mouse with iodine cotton balls. Use a 200μL gun to repeatedly blow and aspirate the cell suspension to mix it evenly, and use a needle to absorb the cell suspension of each group, paying attention to eliminating bubbles in the needle tube. The needle is inserted at an angle of about 45 degrees, and passes through the subcutaneous area at an angle of about 15 degrees for about 1 cm. When it reaches the armpit, the cell suspension is injected at a uniform speed, and the needle is removed using a spiral needle withdrawal method to avoid leakage.

[0080] e. Replace SPF corn bedding, feed and sterilized drinking water every 4 days, measure the body weight of nude mice, and observe whether the behavior of nude mice is abnormal or tumors are formed.

[0081] f. When subcutaneous tumor formation was observed, the nude mice were weighed every other day and the longest and shortest sides of the tumor were measured with a vernier caliper. The tumor volume was calculated using the formula V = (a × b2) / 2 (a represents the longest side of the tumor, and b represents the shortest side of the tumor). The mice were randomly divided into 3 groups, and metal wires Ti, Mg, and Mg0.2Cu were inserted into the tumors of the nude mice in each group until 14 days after treatment.

[0082] g. Micro-CT scanning was used to observe the formation of tumor cavities. Nude mice were killed by cervical dislocation. After taking photos of tumor-bearing nude mice, the tumor, liver, spleen and kidney were removed using sterile forceps and scissors. The transplanted tumor tissues of each group were weighed and photographed. The tumor was fixed in 4wt% paraformaldehyde for subsequent HE staining.

[0083] 10. HE staining

[0084] (1) Tissue embedding

[0085] 1) Tumor tissues of different groups were immersed in a 4 wt % paraformaldehyde solution and fixed for at least 48 h.

[0086] 2) Dehydration: Tumor tissues of each group were gradually dehydrated in gradient ethanol solutions to remove water from the tissues. The mass concentrations of the ethanol solutions were 70% ethanol, 80% ethanol, 90% ethanol, and 95% ethanol, respectively, and each stage lasted 12 hours.

[0087] 3) Transparency: 40 min each in anhydrous ethanol I and anhydrous ethanol II for further dehydration; 15 min each in xylene I and xylene II to replace the ethanol in the tissue.

[0088] 4) Wax immersion: First, place the transparent tumor tissue sample in a melted paraffin mixture containing xylene for 2 hours, and then transfer it to a melted paraffin solution for 2 to 4 hours.

[0089] 5) Embedding: Embed the wax-soaked tissue sample into a pre-cooled paraffin mold to ensure the correct tissue position.

[0090] 6) Sectioning: Use a microtome to cut the embedded tissue blocks into 4 μm thickness.

[0091] 7) Baking: Place the tissue sections in an oven and heat them at 60°C for 2 hours to ensure that the sections are firmly attached to the glass slide.

[0092] Rabbit experiment

[0093] Three New Zealand white rabbits weighing 2.5 kg were selected. Metal wires Ti, Mg, and Mg0.2Cu were inserted into one side of the rabbit's thyroid gland. 14 days after treatment, the implantation site and the contralateral thyroid tissue were taken to make pathological sections, HE staining, and optical microscope observation. Thyroid function FT3 and FT4 were also tested.

[0094] (2) HE staining

[0095] 1) Dewaxing and hydration: Place each group of tissue paraffin sections on a slide rack and bake at 60°C for 2 hours to improve dewaxing efficiency. Place in xylene I and xylene II for 10 minutes each, anhydrous ethanol, 95% ethanol, 90% ethanol, 80% ethanol, and 70% ethanol for 5 minutes each, and wash the slides with PBS buffer 3 times, 10 minutes each time, to remove the residual ethanol on the slides. Note that the liquid level in all steps must be above the tissue sample on the slide.

[0096] 2) Hematoxylin staining: Soak the tissue sections in hematoxylin solution for 2 minutes. Place the sections in running water for 30 minutes to wash away the excess dye on the slide and the metallic luster on the tissue surface, and finally turn the purple-red hematoxylin into blue-purple.

[0097] 3) Eosin staining: Place tissue sections in 70% ethanol, 80% ethanol, 90% ethanol, and 95% ethanol in turn for 5 minutes each. Soak tissue sections in eosin solution and counterstain for 30 seconds to stain the cytoplasm pink. Absolute ethanol I and absolute ethanol II for 5 minutes each.

[0098] 4) Transparency: 5 min each for xylene I and xylene II.

[0099] 5) Sealing: Add a small amount of neutral gum to the middle of the tissue sample on the glass slide, cover it with a cover slip, and gently press until the neutral gum covers the tissue sample. After the glue is naturally air-dried, take pictures under a microscope.

[0100] 11. Mechanical properties testing

[0101] The tensile properties of the tensile specimens were tested at room temperature (20°C) at a constant rate of 0.01 mm / s using an Instron 5966 electronic universal material testing machine, and the tensile strength and elongation at break were calculated.

[0102] 2. Antibacterial effect:

[0103] In terms of antibacterial effect, the previous patent technology "A biodegradable magnesium alloy with strong antibacterial function (publication number CN104645422A)" has proved that magnesium-copper alloy (Mg0.2Cu) has a dual antibacterial effect on Escherichia coli and Staphylococcus aureus, combining alkaline antibacterial and copper ion antibacterial effects, showing excellent anti-bacterial infection function.

[0104] 3. Equipment: Easy to operate

[0105] The simultaneous thyroid biopsy combined with biodegradable magnesium alloy anti-tumor microneedle implantation treatment device of the present invention can simultaneously complete biopsy sampling and anti-tumor microneedle implantation treatment by directly setting the magnesium alloy microneedle in the biopsy needle. During the puncture biopsy process, the anti-tumor material is implanted into the target lesion through the push rod, which simplifies the operation process and avoids the damage to the patient caused by multiple punctures. The device fundamentally provides convenience for patients who need to undergo target lesion puncture biopsy and thyroid treatment at the same time, and provides a new treatment method for patients who are not suitable for traditional surgery and thermal ablation.

[0106] like Figure 3-Figure 18As shown in the figure, the results of the study on the anti-thyroid cancer activity of biodegradable magnesium-based metals show that Mg-based alloy implant materials exhibit excellent performance in many aspects. First, the material significantly inhibits the proliferation of thyroid cancer cells, and cell proliferation-related experiments show that it has a high efficiency in anti-tumor growth. Secondly, the alloy material can significantly reduce the risk of tumor spread by inhibiting the invasion and metastasis of cancer cells, and this effect has been quantitatively reflected in the invasion and metastasis experiment. In addition, the material can effectively induce apoptosis of tumor cells by promoting the apoptosis pathway, which is proved by flow cytometry experiments, further confirming its ability to inhibit the malignant biological behavior of tumors. At the same time, Mg-based alloy implant materials show low systemic toxicity in vivo, and the results of organ histological examinations show that it has minimal damage to normal tissues. Finally, the antibacterial activity and excellent mechanical properties of the material are also confirmed. In summary, biodegradable magnesium-based metals show comprehensive technical advantages in the treatment of anti-thyroid cancer, providing a strong scientific basis for clinical application.

[0107] like Figure 3 As shown in the figure, the MTT method was used to detect the effects of Ti, Mg, and Mg0.2Cu alloy extracts on the proliferation inhibition rate of thyroid cancer cells. It can be seen that compared with the control group Ti group, Mg and Mg0.2Cu alloy extracts treated thyroid cancer cells TPC-1 and BHT-101 for 6 hours inhibited cell proliferation in a time-dependent manner, but had no significant cytotoxic effect on the normal human thyroid cell line NTHY-ORI 3-1.

[0108] like Figure 4 As shown, the toxicity of Ti, Mg, and Mg0.2Cu alloy extracts on thyroid cancer cells was observed by live and dead cell staining. It can be seen that compared with the control group Ti group, Mg and Mg0.2Cu alloy extracts treated thyroid cancer cells TPC-1 and BHT-101 for 24 hours can increase the proportion of dead cells.

[0109] like Figure 5 As shown, the cell clone formation experiment detected the effects of Ti, Mg, and Mg0.2Cu alloy extracts on the clone formation ability of thyroid cancer cells. It can be seen that compared with the control group Ti group, the cell clone size and number in the Mg and Mg0.2Cu alloy groups were significantly smaller, and the cell clone formation ability was significantly inhibited.

[0110] like Figure 6 As shown in the figure, the cell scratch experiment detected the effects of Ti, Mg, and Mg0.2Cu alloy extracts on the migration ability of thyroid cancer cells. It can be seen that compared with the control group Ti group, Mg and Mg0.2Cu alloys can significantly delay the cell healing speed and the relative cell migration rate is significantly reduced.

[0111] like Figure 7As shown in the figure, the Transwell experiment detected the effects of Ti, Mg, and Mg0.2Cu alloy extracts on the invasion and migration ability of thyroid cancer cells. It can be seen that after 24 hours of treatment of thyroid cancer cells TPC-1 and BHT-101 with Mg and Mg0.2Cu alloy extracts, the number of cells invading and migrating through the polycarbonate membrane of the chamber and the polycarbonate membrane of the chamber covered with Matrigel was significantly reduced compared with the control group Ti group.

[0112] like Figure 8 As shown in the figure, the effects of Ti, Mg, and Mg0.2Cu alloy extracts on the formation of filopodia in thyroid cancer cells were observed by scanning electron microscopy. It can be seen that after 24 hours of treatment of thyroid cancer cells TPC-1 and BHT-101 with Mg and Mg0.2Cu alloy extracts, the number of lamellipodia and filopodia formed on the surface of tumor cell membranes was significantly reduced, and the length was significantly shortened compared with the control group Ti group.

[0113] like Fig. 9 As shown in the figure, by immunofluorescence labeling of cytoskeletal proteins F-actin and ɑ-tublin proteins, and observing the effects of Ti, Mg, and Mg0.2Cu alloy extracts on the extension state of the thyroid cancer cell skeleton under a confocal microscope, it can be seen that compared with the control group Ti group, Mg and Mg0.2Cu alloy extracts treated thyroid cancer cells TPC-1 and BHT-101 for 24 hours can affect the rearrangement of F-actin in the cells and aggregate at the cell edge, but there is no significant change in the effect on ɑ-tublin protein.

[0114] like Fig.10 As shown in the figure, the effects of Ti, Mg, and Mg0.2Cu alloy extracts on thyroid cancer cell apoptosis were detected by flow cytometry. It can be seen that after 24 hours of treatment of thyroid cancer cells TPC-1 and BHT-101 with Mg and Mg0.2Cu alloy extracts, the cell apoptosis rates (early and late) were significantly increased compared with the control group Ti group.

[0115] like Fig.11 As shown in the figure, it can be seen from the flow chart of thyroid cancer nude mouse modeling that after tumor cells were implanted subcutaneously on the left back of nude mice, tumor masses began to appear about 10 days later, and nude mice with tumors that were too large or too small were removed. Ti, Mg and Mg0.2Cu rods of the same size, volume and surface area were inserted into the tumors of each group. During the treatment, the diet, activity and mental state of the nude mice in each group were observed, and no obvious abnormalities were found.

[0116] like Fig.12 , Fig.13As shown, from the photos of the nude mice in each group being killed on the 14th day of treatment, the peeled tumor specimens and the statistical chart of the weight of the subcutaneous transplanted tumors in each group of nude mice, it can be seen that compared with the control group Ti group, the tumor volume in the mice treated with Mg and Mg0.2Cu was significantly reduced.

[0117] like Fig.14 As shown, from the Micro-CT images of nude mice in each group on the 14th day of treatment, it can be seen that compared with the control group Ti group, the ablated tumor volume in the mice was significantly increased or the residual tumor volume was significantly reduced after the implantation of Mg and Mg0.2Cu materials.

[0118] like Fig.15 As shown, from the corrosion rate diagram of Mg and Mg0.2Cu metal materials immersed in simulated liquid for different time periods, it can be seen that there is no significant difference in the corrosion rate of Mg and Mg0.2Cu metal materials in vitro.

[0119] like Fig.16 As shown in the figure, the morphological effects of Ti, Mg, and Mg0.2Cu alloys on the liver, spleen, and kidney of nude mice 14 days after implantation showed that the Ti, Mg, and Mg0.2Cu implant materials did not change the physiological structure of the renal cortex of tumor-bearing mice; the normal white pulp and red pulp of the spleen tissue were neatly arranged and the marginal area was clearly outlined in all three groups, and no significant abnormal changes were observed; the liver tissue structure with clear central veins, liver plates, and hepatic sinusoids was observed in all three groups, and large and round nuclei were observed in the hepatocytes, and no obvious abnormal changes such as dilation of the central vein or tissue edema were observed between the groups.

[0120] like Fig.17 As shown in the figure, from the fixation process of rabbit thyroid tissue implanted with Ti, Mg, and Mg0.2Cu alloys and the levels of FT3 and FT4 in serum 14 days after surgery, it can be seen that compared with the control group Ti group, the levels of FT3 and FT4 in the serum of rabbits in the Mg and Mg0.2Cu groups were significantly reduced.

[0121] like Fig.18 As shown in the figure, the effects of Ti, Mg, and Mg0.2Cu alloys on the thyroid tissue morphology of rabbits 14 days after implantation showed that the thyroid follicles and epithelial cells on the surgical and contralateral sides of the three groups of rabbits had normal morphology and size, and no obvious lymphocyte infiltration and interstitial fibrosis were observed. The Ti, Mg, and Mg0.2Cu implant materials did not cause obvious histological changes.

[0122] The implementation results show that the simultaneous thyroid tumor biopsy and therapeutic biodegradable magnesium alloy implant device of the present invention has application value in the diagnosis and treatment of thyroid cancer, and is expected to provide a gentle, safe and effective alternative treatment method for thyroid cancer.

[0123] The protection scope of the present invention is not limited thereto. Any technician familiar with the technical field can make equivalent replacements or changes according to the technical solutions and concepts of the present invention within the technical scope disclosed by the present invention, and all of them should be covered by the protection scope of the present invention.

Claims

1. A biodegradable magnesium alloy implant device for simultaneous thyroid tumor biopsy and treatment, characterized in that: The device includes a biopsy needle, a stopper, a magnesium alloy microneedle, a scale mark, a transparent needle handle, a Luer interface, and a push rod. The specific structure is as follows: One end of the hollow biopsy needle is inserted into one end of the transparent needle handle, and one end of the push rod is inserted into the other end of the transparent needle handle; a Luer interface is arranged on the outer side of the other end of the transparent needle handle, and is matched and connected with a corresponding female Luer connector through the Luer interface; a magnesium alloy microneedle is arranged on the upper part of the hollow inner cavity of the biopsy needle, and the front end of the magnesium alloy microneedle is a pointed end, and a stopper is arranged on the outer side of the magnesium alloy microneedle on the biopsy needle, the stopper is elastic and corresponds to the shape of the magnesium alloy microneedle, the front end of the stopper extends into the biopsy needle, and the rear end of the magnesium alloy microneedle is a plane, one end of the push rod extends into the hollow inner cavity of the biopsy needle and corresponds to the rear end of the magnesium alloy microneedle, and a scale mark is opened on the side of the biopsy needle.

2. The simultaneous thyroid tumor biopsy and therapeutic biodegradable magnesium alloy implant device according to claim 1, characterized in that: The size of the magnesium alloy microneedle is: diameter Φ=0.2mm~0.8mm, length 3mm~6mm.

3. The simultaneous thyroid tumor biopsy and therapeutic biodegradable magnesium alloy implant device according to claim 1 or 2, characterized in that: The magnesium alloy microneedle adopts magnesium-copper alloy Mg0.2Cu.

4. The simultaneous thyroid tumor biopsy and therapeutic biodegradable magnesium alloy implant device according to claim 1, characterized in that: By directly setting the magnesium alloy microneedle in the biopsy needle, the magnesium alloy microneedle is implanted into the lesion while the biopsy is being taken.

5. The simultaneous thyroid tumor biopsy and therapeutic biodegradable magnesium alloy implant device according to claim 4, characterized in that: Under ultrasound-assisted guidance, the tumor-therapeutic magnesium alloy microneedle in the biopsy needle is implanted into the lesion through a push rod. At the same time, the biopsy needle takes thyroid tissue samples around the implanted material.

6. The simultaneous thyroid tumor biopsy and therapeutic biodegradable magnesium alloy implant device according to claim 1, characterized in that: By setting scale marks on the biopsy needle, the insertion depth can be calculated while puncturing.

7. The simultaneous thyroid tumor biopsy and therapeutic biodegradable magnesium alloy implant device according to claim 1, characterized in that: During use, under the guidance of ultrasound, the needle is inserted layer by layer along the predetermined puncture path in the patient's thyroid tissue to reach the lesion; the magnesium alloy microneedle customized according to the size of the lesion before the operation is implanted into the lesion, and sampling is performed around the implanted magnesium alloy microneedle. After sampling, the biopsy needle is withdrawn; the biopsy needle is retracted, the wound is disinfected and bandaged, and the operation is completed.